XenoPort (XNPT)

5.38 -0.50  -8.50%  Jun 01, 8:00PM Go Pro
Watch this stock
View Full Chart XNPT Price Chart

Key Stats

Market Cap 191.69M
Revenue Growth 2639%
Profit Margin -88.10%
Earnings Yield -13.20%
Dividend Yield 0.00%
Earnings Per Share TTM -0.71
PE Ratio
Price / Sales Ratio 3.582
52 Week High 8.07
52 Week Low 3.46
Beta 0.4177
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

News

Jun 01 $XNPT how is this going to come into play with the decision on saturday June 9th,.???? by markf
Jun 01 XenoPort Announces New Employment Inducement Award Business Wire
Jun 01 RT @b_rad: Done with $ALXA (for now), moved to $XNPT for run up next week @b_rad great move! by Bw1128
Jun 01 Done with $ALXA (for now), moved to $XNPT for run up next week by b_rad
Jun 01 $XNPT great time to get in before next friday! by Bw1128
Jun 01 $AMRN and $XNPT -8% today. unreal. by GPrime
Jun 01 Good time to make new position? RT @BioRunUp: $XNPT ugly drop, support broke around $5.60... by b_rad
Jun 01 $XNPT Herceptin already approved drug for RLS. sNDA to use Herceptin for zoster virus associated with "shingles." Expands use of drug. by SciGuy
May 31 so is $XNPT going to see a run-up or did it already happen? (did it start on 5/11?). we're about a week away from PDUFA by GPrime
May 31 $XNPT Looking for a starter here going into next week by SpiritWarrior
May 26 3 Health-Care Stocks Crushing the Market Fool
May 24 XENOPORT INC Files SEC form 8-K, Other Events
May 24 XenoPort submits Investigational New Drug application for multiple sclerosis
May 24 XenoPort Submits Investigational New Drug Application for XP23829 as a Potential Trea...

Profile

Exchange: NASDAQGM       Sector: Healthcare       Industry: Biotechnology

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). XenoPort is down 29.76% over the last year vs S&P 500 Total Return down 0.60%, Protalix BioTherapeutics down 4.27%, and Repligen Corporation up 7.63%.

  • XNPT Total Returns
  • ^SPXTR Total Returns
  • PLX Total Returns
  • RGEN Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Get Quote for

Pro Strategies Featuring XNPT

Did XenoPort make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

XNPT Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
XNPT 5.38 -0.50 -8.50% 191.69M
XMPT 27.90 -0.22 -0.78%
XME 39.57 +0.17 +0.43%
XLVS 32.49 -0.66 -1.99%
XLV 35.51 -0.64 -1.77%
XLUS 29.04 -0.17 -0.56%
XLU 35.71 -0.15 -0.42%
XLP 33.16 -0.62 -1.84%
XLNX 31.00 -0.97 -3.03% 8.117B
XLK 27.20 -0.73 -2.61%
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close